Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Plunges 7%; BSE HEALTHCARE Index Up 0.2%
Thu, 8 Aug 16:23

ASTRAZENECA PHARMA Plunges 7%; BSE HEALTHCARE Index Up 0.2%Image source: CreativaImages/www.istockphoto.com

ASTRAZENECA PHARMA share price has plunged 7% and is presently trading at Rs 6,562.0.

Meanwhile, the BSE HEALTHCARE index is at 40,926.1 (up 0.2%).

Among the top losers in the BSE HEALTHCARE index today are CAPLIN POINT (down 6.6%) and FDC (down 3.7%).

ALKEM LABORATORIES (up 3.6%) and ERIS LIFESCIENCES (up 3.3%) are among the top gainers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 3,810.8 to Rs 6,562.0, registering a gain of Rs 2,751.2 (up 72.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 40,926.1, registering a gain of 44.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 115.2%), GSK Pharma (up 105.8%) and SUVEN PHARMACEUTICALS (up 104.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 78,886.2 (down 0.7%).

The top losers among the BSE Sensex today are Asian Paints (down 3.6%) and Infosys (down 2.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,098.7 (down 0.8%). LTIMINDTREE and Grasim Industries are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 78,886.2, registering a gain of 12,932.7 points (up 19.6%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit grew 128.6% YoY to Rs 395 million for the quarter ended March 2024, compared to a profit of Rs 173 million a year ago. Net sales rose 34.6% to Rs 3,832 million during the period as against Rs 2,847 million in January-March 2023.

For the year ended March 2024, ASTRAZENECA PHARMA reported 62.7% increase in net profit to Rs 1,615 million compared to net profit of Rs 993 million during FY23. Revenue of the company grew 29.2% to Rs 12,955 million during FY24.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 101.6.


Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Plunges 7%; BSE HEALTHCARE Index Up 0.2%". Click here!